Introduction
Outbreaks of influenza virus infection in hospitalized patients have been reported for many years in groups such as onco-haematological patients, transplant recipients, paediatric patients, and in neonatal intensive care units. 1e5 Since the 2009 pandemic with novel influenza A (H1N1)pdm09 virus, tests for early and rapid diagnosis of viral infections have become widely used. 6 With the wide availability of accurate tests for influenza A (H1N1)pdm09 infection, several outbreaks caused by this virus in units treating immunocompromised patients have been documented. 7e9 In the intensive care units (ICUs), patients with influenza A (H1N1)pdm09 virus infection continue to be a seasonal problem, and experience a high mortality rate. 10, 11 However, to our knowledge, no large outbreaks of infection due to influenza A (H1N1)pdm09 virus acquired on ICUs have been published.
In Spain, there is a registry of patients with influenza A virus infection who required ICU admission for their treatment. 12 Most patients with influenza A (H1N1)pdm09 virus infections had community-acquired infections and were admitted early in the course of their illnesses with severe acute respiratory failure requiring respiratory support. A smaller group of patients had nosocomial infection influenza A (H1N1)pdm09 virus. Previous studies have assessed independent factors related with mortality in hospitalized patients infected with the influenza A (H1N1)pdm09 virus, including specifically ICU patients and other specific patient groups. 13e21 However, in none of these has hospital-acquired influenza A (H1N1)pdm09 virus infection been considered as a risk factor for death.
This study was designed to analyse available data from the Spanish Working Group on Severe Pandemic Influenza A (GET-GAG) of the Spanish Society of Critical Care Medicine and Coronary Units (SEMICYUC) (GETGAG/SEMICYUC) registry of patients admitted to the ICU diagnosed with influenza A (H1N1) pdm09 virus infection, in order to assess the clinical profiles and outcomes of those with hospital-acquired infection. It was hypothesized that acquisition of influenza A (H1N1)pdm09 infection in the hospital was an independent risk factor for mortality.
Methods

Design and study population
This was a cohort, observational, and multicentre study based on a secondary analysis of patients included in the GETGAG/SEMICYUC registry. Between January 1 st , 2009 and December 31 st , 2015, data for all patients with microbiologically confirmed diagnosis of influenza A (H1N1)pdm09 virus infection admitted to 148 ICUs throughout Spain were included in the GETGAG/SEMICYUC registry. The identities of patients were anonymized and individual patient informed consent was not obtained given the non-interventional and retrospective nature of the study. The GETGAG/SEMICYUC registry was approved by the Institutional Review Board of Hospital Joan XXIII University Hospital of Tarragona, Spain, and analysis of the present study was approved by the Clinical Research Ethical Committee of Parc de Salut Mar of Barcelona, Spain.
Case definition
All patients with respiratory infection in which influenza A (H1N1)pdm09 virus was identified by real-time polymerase chain reaction performed according to recommendations of the Centers for Disease Control and Prevention were included in the analysis. 22 Other virological studies were not performed. Clinical manifestations included two or more of the following signs and symptoms: fever (>38 C), cough, bronchial expectoration, and myalgias associated with clinical signs of organ or system failure, such as respiratory failure, haemodynamic instability or altered consciousness. Information was provided by physicians of the participating ICUs according to the patient's medical history, laboratory data, and radiological findings. Patients aged <15 years were not included in the registry.
Patients were classified according to the time at which the diagnosis of influenza A (H1N1)pdm09 virus infection was established. Community acquisition was defined as diagnosis within two days of admission to hospital; cases diagnosed seven or more days after admission, and where there was no suspicion of viral respiratory infection on admission, were defined as hospital-acquired; patients who did not fall into either of the above groups were deemed to be unclassified.
Data collection
A case report form (CRF) was designed for data collection, including demographics (age, sex); time-related variables (date of hospital admission, date of ICU admission, length of hospital stay and date of diagnosis of influenza A (H1N1)pdm09 virus infection, length of hospital and ICU stay); comorbidities; severity of illness on admission; presenting manifestations of infection; treatments administered (oseltamivir, inotropic drugs, corticoids, mechanical ventilation); and intra-ICU mortality. The severity of infection was assessed according to the Acute Physiology and Chronic Health Evaluation (APACHE II) score within the first 24 h of ICU admission, and the level of organ failure using the Sequential Organ Failure Assessment (SOFA) score on ICU admission. 23, 24 Definitions of communityacquired or hospital-acquired pneumonia were those recommended by the American Thoracic Society and the Infectious Diseases Society of America. 25, 26 
Statistical analysis
Categorical variables were expressed as frequencies and percentages, and continuous variables as mean and standard deviation (SD) when data followed a normal distribution, or as median and interquartile range (25 th e75 th percentile) when distribution departed from normality. Differences between patients with influenza A (H1N1)pdm09 virus infection acquired in the hospital or in the community were analysed using the c 2test, or Fisher's exact test for categorical variables, or Student's t-test or the ManneWhitney U-test for continuous data. Statistical significance was set at P < 0.05. Cumulative survival for patients with influenza A (H1N1)pdm09 virus infection according to time of diagnosis was assessed using KaplaneMeier plot. Cox regression analyses were used to assess: (i) independent factors associated with hospital-acquired influenza A (H1N1)pdm09 virus infection, and (ii) independent factors associated with mortality in patients diagnosed with influenza A (H1N1)pdm09 infection admitted to the ICU. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Data were analysed using the Statistical Package for the Social Sciences (SPSS, Chicago, IL, USA) for Windows 15.0.
Results
A total of 2421 patients diagnosed with influenza A (H1N1) pdm09 virus infection were included in the analysis. There were 1103 patients (45.6%) with community-acquired infections and 224 (9.3%) whose infections were acquired during their stay in the hospital. The remaining 1094 cases (45.2%) were unclassified, or had missing data, and were excluded from the analysis (Figure 1 ). Table I shows demographic data, comorbidities, severity, clinical presentation, and outcomes of patients with hospital-acquired and community-acquired influenza A (H1N1)pdm09 virus infections. Male patients predominated in both groups but patients with hospital-acquired influenza A infection were significantly older, showed higher APACHE II and SOFA scores on ICU admission and required mechanical ventilation more frequently and for longer. Also, a significantly higher percentage of patients with hospitalacquired infections were immunocompromised or had underlying haematological disorders. The percentage of patients receiving influenza vaccination was significantly higher in the hospital-acquired group, although the overall rate of vaccination against influenza was low. The length of stay in the ICU and in the hospital was significantly longer among patients with hospital-acquired infections. Mortality in patients with hospital-acquired influenza A (H1N1)pdm09 virus infection was more than two times higher than in patients with community-acquired influenza A (39.2% vs 18.8%; P < 0.001) (Table I ). In the Cox regression analysis, age, absence of influenza vaccination, and need of mechanical ventilation were independent factors associated with hospital-acquired influenza A infection.
Outcome data were available for 1245 patients (Table II) ; variables related to severity of illness on ICU admission, comorbidities, need for respiratory and/or haemodynamic support and extrarenal depuration procedures were significantly associated with mortality. Also, mortality among influenza-vaccinated patients was significantly higher than among non-vaccinated patients (10.3% vs 4.2%; P < 0.001). Time-to-event analysis showed an association between time to diagnosis of influenza A (H1N1)pdm09 virus infection and mortality (Figure 2 ).
In the Cox regression analysis, independent variables significantly associated with intra-ICU mortality were hospitalacquired influenza A (H1N1)pdm09 virus infection (OR: 1.63; 95% CI: 1.33e1.98; P < 0.001), APACHE II score on ICU admission (1.09; 1.06e1.11; P <0.001), haematological disease (3.19; 1.78e5.73; P < 0.001), extrarenal depuration procedures (4.20; 2.61e6.77; P < 0.001), and mechanical ventilation (4.34; 2.62e7.20; P < 0.001). 
Patients with influenza
Discussion
This study shows that infection with influenza A (H1N1) pdm09 virus acquired in the hospital is an independent risk factor for death in critically ill patients admitted to the ICU. This is an important and clinically relevant finding. The study also shows that patients with hospital-acquired influenza A (H1N1)pdm09 infection present a clinical profile, severity level, and therapeutic requirements different to communityacquired influenza.
Although the definition of infections acquired in the hospital used for bacterial and fungal infections establishes a 48 h time interval for classifying an infection as hospital-acquired, this rule cannot necessarily be applied to viral infections for which the incubation period may be up to seven days. In the present analysis, hospital-acquired influenza A (H1N1)pdm09 infection was defined when diagnosis was made from the seventh day of hospital stay in a patient with no previous diagnostic suspicion of viral infection and/or initiation of treatment with oseltamivir. For this reason a high number of patients diagnosed with influenza A (H1N1)pdm09 virus infection were excluded from the comparative analysis because of doubts regarding the dates of hospital admission or diagnosis of influenza. According to these criteria, 9.3% of cases in our series were classified into the group of hospital-acquired influenza A (H1N1)pdm09 infection. In the UK, during the 2009e2010 pandemic influenza A (H1N1)pdm09 outbreak, 2% of hospitalized cases were considered hospital-acquired infections, with a median length of hospitalization before symptom onset of 11 days. 27 In Spain, 6.1% of the first 131 patients with pandemic influenza A (H1N1) infection who died were cases of infections acquired in the hospital setting. 28 Patients with hospital-acquired influenza A (H1N1)pdm09 infection showed a different profile to patients with community-acquired infections; they were older, more likely to have haematological disease and immunosuppression, and they had a higher level of severity of illness on ICU admission, which resulted in a greater number of therapeutic interventions during their ICU stay. The fact that almost 10% of cases of influenza A (H1N1)pdm09 infections admitted to the ICU had been classified as acquired in the hospital justifies the need to maximize measures for preventing its spread in epidemic periods and to include active search of influenza A cases among hospitalized patients with longer stays and signs of infection without a clear primary focus, particularly in patients immunocompromised or with haematological disorders. 29, 30 The mortality rate in patients with hospital-acquired influenza A (H1N1)pdm09 was double that in those with community-acquired infections. This probably reflects the higher severity of illness, as indicated by severity scores on ICU admission and the greater need for vasoactive drugs and mechanical ventilation. Although the rates of vaccination were very low in patients with both hospital-acquired and community-acquired influenza A (H1N1)pdm09 virus infection, a higher proportion of the former had been immunized; this probably reflects the greater number of comorbidities (COPD, renal failure, heart failure) for which vaccination is recommended. 31e34 Our study reinforces the need to prevent transmission of influenza A (H1N1)pdm09 in hospitals. Precautions include exclusion of visitors and staff with suspected influenza and the use of masks and good hand hygiene. Immunization of healthcare personnel against influenza is a key component of such strategies, but unfortunately campaigns to improve the uptake of vaccination have often had limited success. 31e34 We believe that our data, underlining the severity of hospital-acquired influenza A (H1N1)pdm09 infection, will provide useful support to campaigns to prevent transmission of influenza in hospitals.
Limitations of the study include the lack of consensus diagnostic criteria for classifying patients with hospitalacquired influenza; by using a relatively stringent definition of hospital-acquired infection our study may have understated the true risk of acquiring influenza A (H1N1)pdm09 in hospitals. In this multicentre study there were no single diagnostic or treatment protocols, meaning that there may have been case ascertainment and treatment biases.
Our data show a decrease in cases of nosocomial influenza A infection in the second half of the study period, whereas the number of community-acquired cases remained relatively constant (Table I) . Although possible reasons for this were not investigated, it is possible that national campaigns directed towards families and healthcare personnel, and consensus recommendations published by Spanish scientific societies in 2012, may have had some effect. 30 In conclusion, this study shows that there are important differences in patients diagnosed with influenza A (H1N1) pdm09 virus infection admitted to the ICU according to whether their infections were acquired in the community or in hospital. The finding that hospital-acquired infections were associated with a longer ICU stay and higher intra-ICU mortality supports the need for prompt testing of patients and/or administration of empiric antiviral treatment. Finally, our data emphasize the importance of infection prevention and control measures to reduce the risk of transmission of influenza viruses to hospitalized patients. 
